Cargando…

Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer

Bladder cancer is the most common malignancy of the urinary tract for which the accurate measurement of minimal residual disease is critical to treatment and determining prognosis. Although cystoscope examination and voided urine cytology remain the current standard of care for detecting residual di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Chen, Wu, Kaijie, Wang, Weiyi, Guan, Zhenfeng, wang, Lei, Wang, Xinyang, Wang, Rong, Liu, Li, Fan, Jinhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354866/ https://www.ncbi.nlm.nih.gov/pubmed/27902468 http://dx.doi.org/10.18632/oncotarget.13578

Ejemplares similares

Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus
por: Zhang, Tingting, et al.
Publicado: (2015)

Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression
por: Huang, Zhixin, et al.
Publicado: (2019)

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent
por: Yin, Jie, et al.
Publicado: (2019)

Ultrasmall superparamagnetic iron oxide nanoparticles for enhanced tumor penetration
por: Feng, Xue, et al.
Publicado: (2023)

HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model
por: Zhu, Jianning, et al.
Publicado: (2018)

HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model
por: Zhu, Jianning, et al.
Publicado: (2021)

MRI of High-Glucose Metabolism Tumors: a Study in Cells and Mice with 2-DG-Modified Superparamagnetic Iron Oxide Nanoparticles
por: Shan, Xiu Hong, et al.
Publicado: (2015)

Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles
por: Wang, Baoyan, et al.
Publicado: (2019)

HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells
por: GUAN, ZHENFENG, et al.
Publicado: (2013)

Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44
por: Wang, Weiyi, et al.
Publicado: (2021)

Self-Assembled Superparamagnetic Iron Oxide Nanoclusters for Universal Cell Labeling and MRI
por: Chen, Shuzhen, et al.
Publicado: (2016)

Synthesis and study of cell-penetrating peptide-modified gold nanoparticles
por: Boussoufi, Félix, et al.
Publicado: (2018)

Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma
por: Li, Youwei, et al.
Publicado: (2012)

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy
por: Yang, Zhen, et al.
Publicado: (2018)

Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects
por: Deh, Kofi, et al.
Publicado: (2020)

Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance
por: Dadfar, Seyed Mohammadali, et al.
Publicado: (2020)

The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles
por: Zheng, Xiu-Chai, et al.
Publicado: (2018)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

Evaluation of non-targeting, C- or N-pH (low) insertion peptide modified superparamagnetic iron oxide nanoclusters for selective MRI of liver tumors and their potential toxicity in cirrhosis
por: Mahmood, Abdulrahman Ahmed, et al.
Publicado: (2019)

In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles
por: Zhu, Yunkai, et al.
Publicado: (2015)

Endothelial progenitor cells in the peripheral blood of patients with moyamoya disease labeled with superparamagnetic iron oxide in vitro for MRI detection
por: Wang, Xirui, et al.
Publicado: (2020)

Synthesis conditions and characterization of superparamagnetic iron oxide nanoparticles with oleic acid stabilizer
por: Wulandari, Anggita Dipika, et al.
Publicado: (2022)

Synthesis and Study of Cell-Penetrating Peptide-Modified Gold Nanoparticles [Corrigendum]
Publicado: (2021)

In vivo MRI visualization of mesh shrinkage using surgical implants loaded with superparamagnetic iron oxides
por: Kuehnert, Nicolas, et al.
Publicado: (2011)

Clinically Translatable Cell Tracking and Quantification by MRI in Cartilage Repair Using Superparamagnetic Iron Oxides
por: van Buul, Gerben M., et al.
Publicado: (2011)

MRI detection of endothelial cell inflammation using targeted superparamagnetic particles of iron oxide (SPIO)
por: Chan, Joyce M. S., et al.
Publicado: (2017)

Neural Induction Potential and MRI of ADSCs Labeled Cationic Superparamagnetic Iron Oxide Nanoparticle In Vitro
por: Ma, Weiqiong, et al.
Publicado: (2018)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
por: Gonzalez-Rodriguez, Roberto, et al.
Publicado: (2018)

Polymer-coated superparamagnetic iron oxide nanoparticles as T(2) contrast agent for MRI and their uptake in liver
por: Ali, Lamiaa MA, et al.
Publicado: (2017)

Superparamagnetic iron oxide-enhanced MRI-guided stereotactic ablative radiation therapy for liver metastasis
por: Hama, Yukihiro, et al.
Publicado: (2021)

Washing effect on superparamagnetic iron oxide nanoparticles
por: Mireles, Laura-Karina, et al.
Publicado: (2016)

Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress
por: Sun, Zhe, et al.
Publicado: (2023)

Collagen-coated superparamagnetic iron oxide nanoparticles as a sustainable catalyst for spirooxindole synthesis
por: Azarnier, Shima Ghanbari, et al.
Publicado: (2022)

Synthesis of Biocompatible Superparamagnetic Iron Oxide Nanoparticles (SPION) under Different Microfluidic Regimes
por: Schemberg, Jörg, et al.
Publicado: (2022)

Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy
por: Yang, Rui-Meng, et al.
Publicado: (2016)

Polydopamine Modified Superparamagnetic Iron Oxide Nanoparticles as Multifunctional Nanocarrier for Targeted Prostate Cancer Treatment
por: Singh, Nimisha, et al.
Publicado: (2019)

Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment
por: Reczyńska, Katarzyna, et al.
Publicado: (2020)

In Vivo MRI Tracking of Polyethylenimine-Wrapped Superparamagnetic Iron Oxide Nanoparticle–Labeled BMSCs for Cartilage Repair: A Minipig Model
por: Chen, Jiarong, et al.
Publicado: (2013)

AB131. Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience
por: He, Dalin, et al.
Publicado: (2014)

Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
por: Di Marco, Mariagrazia, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ogt3imqp0i00qohcg2vq69ufhc